Microtubule-associated protein tau in cerebrospinal fluid (CSF) has been pr
oposed as a diagnostic marker for Alzheimer's disease (AD), but there is ov
erlap between AD patients and non-AD controls. To improve the diagnostic ac
curacy, we measured phosphorylated tau in CSF, because phosphorylated tau a
ccumulates as pathological paired helical filaments in neurons of the AD br
ain. Immunoblot showed that CSF contained a 32 kDa N-terminal fragment of t
au that was partially phosphorylated on Ser199, Thr231 and Ser235. A sandwi
ch enzyme immunoassay revealed that phosphorylated CSF-tau levels were sign
ificantly higher in AD patients than those in non-AD controls. Discriminati
on between the two groups was clearer in phosphorylated CSF-tau than in tot
al CSF-tau. The data indicate that elevated phosphorylated CSF-tau level is
a more specific diagnostic marker for AD. (C) 1999 Elsevier Science Irelan
d Ltd. All rights reserved.